These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 26537661)

  • 21. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
    Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
    Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal infusions for intractable cancer pain: a qualitative study of the impact on a case series of patients and caregivers.
    Hawley P; Beddard-Huber E; Grose C; McDonald W; Lobb D; Malysh L
    Pain Res Manag; 2009; 14(5):371-9. PubMed ID: 19862372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(1):1-51. PubMed ID: 27026796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal drug delivery system (IDDS) for cancer pain management: a review and updates.
    Upadhyay SP; Mallick PN
    Am J Hosp Palliat Care; 2012 Aug; 29(5):388-98. PubMed ID: 22089523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal Therapy for Cancer-Related Pain.
    Bruel BM; Burton AW
    Pain Med; 2016 Dec; 17(12):2404-2421. PubMed ID: 28025375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
    Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
    J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
    Mitchell A; McGhie J; Owen M; McGinn G
    Palliat Med; 2015 Jun; 29(6):554-63. PubMed ID: 25690600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal Analgesia via a Percutaneous Port With Patient-Controlled Intrathecal Analgesia for the Management of Movement-Evoked Breakthrough Cancer Pain of Refractory Lower Extremity Cancer Pain: A Retrospective Review.
    Zhou L; Guo Z
    Pain Physician; 2023 Jul; 26(4):375-382. PubMed ID: 37535777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug delivery systems.
    Erdine S; De Andrés J
    Pain Pract; 2006 Mar; 6(1):51-7. PubMed ID: 17309710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing Initial Intrathecal Drug Ratio for Refractory Cancer-Related Pain for Early Pain Relief. A Retrospective Monocentric Study.
    Dupoiron D; Leblanc D; Demelliez-Merceron S; Bore F; Seegers V; Dubois PY; Pechard M; Robard S; Delorme T; Jubier-Hamon S; Carvajal G; Lebrec N
    Pain Med; 2019 Oct; 20(10):2033-2042. PubMed ID: 31329956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of external system and implanted system in intrathecal therapy for refractory cancer pain in China: A retrospective study.
    Qin W; Zhao L; Liu B; Yang Y; Mao P; Xu L; Li P; Shang Y; Zhang L; Fan B
    Brain Behav; 2023 Jan; 13(1):e2851. PubMed ID: 36545706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attitudes of Hospice Providers Regarding Intrathecal Targeted Drug Delivery for Patients With Cancer.
    Warner LL; Moeschler SS; Pittelkow TP; Strand JJ
    Am J Hosp Palliat Care; 2019 Nov; 36(11):955-958. PubMed ID: 31132860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Best practices for intrathecal drug delivery for pain.
    Prager J; Deer T; Levy R; Bruel B; Buchser E; Caraway D; Cousins M; Jacobs M; McGlothlen G; Rauck R; Staats P; Stearns L
    Neuromodulation; 2014 Jun; 17(4):354-72; discussion 372. PubMed ID: 24446870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brief review: Neuraxial analgesia in refractory malignant pain.
    Smyth CE; Jarvis V; Poulin P
    Can J Anaesth; 2014 Feb; 61(2):141-53. PubMed ID: 24233771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Massive clonidine overdose during refill of an implanted drug delivery device for intrathecal analgesia: a review of inadvertent soft-tissue injection during implantable drug delivery device refills and its management.
    Johnson ML; Visser EJ; Goucke CR
    Pain Med; 2011 Jul; 12(7):1032-40. PubMed ID: 21672143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.
    Smyth C; Ahmadzai N; Wentzell J; Pardoe A; Tse A; Nguyen T; Goddard Y; Nair S; Poulin PA; Skidmore B; Ansari MT
    Drugs; 2015 Nov; 75(17):1957-80. PubMed ID: 26501979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathecal Analgesic Drug Delivery is Effective for Analgesia in a Patient with Post-Poliomyelitis Syndrome: A Case Report.
    van Tilburg CW
    Am J Case Rep; 2016 Dec; 17():957-962. PubMed ID: 27980323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit.
    Brogan SE; Winter NB; Abiodun A; Safarpour R
    Pain Med; 2013 Apr; 14(4):478-86. PubMed ID: 23461787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain.
    Xing F; Yong RJ; Kaye AD; Urman RD
    Curr Pain Headache Rep; 2018 Feb; 22(2):11. PubMed ID: 29404792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Labour pain management in a parturient with an implanted intrathecal pump.
    Tarshis J; Zuckerman JE; Katz NP; Segal S; Mushlin PS
    Can J Anaesth; 1997 Dec; 44(12):1278-81. PubMed ID: 9429046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.